A recent study reveals that patients who come off new weight-loss injections like Mounjaro or Wegovy can put back on lost weight far faster than those who stop traditional diet and exercise regimens.
Published data in a prominent medical journal shows that while overweight individuals often shed about a fifth of their total mass while on the medication, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using these medications need to be informed of the potential of fast rebound weight gain when the treatment ends," warns expert Dr. Susan Jebb.
Such speed of regain implies a return to pre-treatment weight within about a year and a half.
Comparing Treatments
The research, which examined dozens of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with other pills.
Researchers point out that individuals who shed pounds through dieting typically have a less rapid creep back—approximately 0.1 kg a month—after stopping.
Understanding the Rapid Regain
Nutrition scientists believe the way of the injections explains the heightened rebound.
These medications copy a body's own chemical called GLP-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous hormone, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement leads to hunger is unsuppressed, making excessive eating much more probable."
An Ongoing Issue?
Health authorities recommend the jabs for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.
Professionals argue that, due to the likelihood of relapse, the therapy should be considered long-term.
This opinion is reinforced by drug manufacturers, who state that the results "highlight the chronic character of excess weight," similar to managing conditions like diabetes.
Patient Experiences
Users who have stopped the medication describe a sudden return of appetite.
"It was like a switch flipping and you're instantly starving," described one woman.
This difficulty is worsened if users have not developed lasting dietary or behavioural modifications during therapy.
Widespread Use
Survey data suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is greater among women compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the medications through private prescriptions rather than public health services.
Finally, researchers stress that while these medications are potent agents for shedding pounds, they are not a magic solution and maintained weight loss likely depends on integrated behavioural changes.